ARKK vs. XLV
ARKK (ARK Innovation ETF) and XLV (State Street Health Care Select Sector SPDR ETF) are both exchange-traded funds - ARKK is a Technology Equities fund actively managed by ARK, while XLV is a Health & Biotech Equities fund tracking the Health Care Select Sector Index. ARKK is actively managed, while XLV is passively managed. Over the past 10 years, ARKK returned 14.94%/yr vs 9.64%/yr for XLV. At a 0.44 correlation, their price movements are largely independent. ARKK charges 0.75%/yr vs 0.08%/yr for XLV.
Performance
ARKK vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKK achieves a -2.56% return, which is significantly lower than XLV's 3.75% return. Over the past 10 years, ARKK has outperformed XLV with an annualized return of 14.94%, while XLV has yielded a comparatively lower 9.64% annualized return.
ARKK
- 1D
- -0.33%
- 1M
- -6.53%
- 6M
- -8.24%
- YTD
- -2.56%
- 1Y
- -3.45%
- 3Y*
- 16.39%
- 5Y*
- -9.13%
- 10Y*
- 14.94%
- ALL TIME*
- 12.69%
XLV
- 1D
- -1.14%
- 1M
- 7.06%
- 6M
- 3.13%
- YTD
- 3.75%
- 1Y
- 22.90%
- 3Y*
- 7.12%
- 5Y*
- 6.00%
- 10Y*
- 9.64%
- ALL TIME*
- 8.56%
ARKK vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARKK ARK Innovation ETF | -2.56% | 35.49% | 8.40% | 69.04% | -66.97% | -23.60% | 152.71% | 35.08% | 3.52% | 87.33% |
XLV State Street Health Care Select Sector SPDR ETF | 3.75% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
Correlation
The correlation between ARKK and XLV is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014 | 0.44 |
Over the past year, the correlation between ARKK and XLV has dropped to 0.17 - well below their long-term average of 0.44, suggesting their price drivers have been diverging.
ARKK vs. XLV - Sectors Allocation Comparison
Sectors
ARKK
XLV
Healthcare
Technology
-
Consumer Cyclical
-
Financial Services
-
Industrials
-
Communication Services
-
Basic Materials
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
ARKK
XLV
Technology
ARKK
XLV
-
Consumer Cyclical
ARKK
XLV
-
Financial Services
ARKK
XLV
-
Industrials
ARKK
XLV
-
Communication Services
ARKK
XLV
-
Basic Materials
ARKK
-
XLV
-
Consumer Defensive
ARKK
-
XLV
-
Energy
ARKK
-
XLV
-
Real Estate
ARKK
-
XLV
-
Utilities
ARKK
-
XLV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKK vs. XLV — Risk / Return Rank
ARKK
XLV
ARKK vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Innovation ETF (ARKK) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKK | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.55 | ||
| Sortino ratioReturn per unit of downside risk | -2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.26 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.11 | 2.20 | -2.31 |
| Martin ratioReturn relative to average drawdown | -0.23 | 5.19 | -5.42 |
Loading charts...
Drawdowns
ARKK vs. XLV - Drawdown Comparison
The maximum ARKK drawdown since its inception was -80.97%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for ARKK and XLV.
Loading charts...
Drawdown Indicators
| ARKK | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.97% | -39.17% | -41.80% |
Max Drawdown (1Y)Largest decline over 1 year | -31.35% | -10.47% | -20.88% |
Max Drawdown (3Y)Largest decline over 3 years | -39.56% | -17.11% | -22.45% |
Max Drawdown (5Y)Largest decline over 5 years | -76.27% | -17.11% | -59.16% |
Max Drawdown (10Y)Largest decline over 10 years | -80.97% | -28.40% | -52.57% |
Current DrawdownCurrent decline from peak | -51.47% | -3.16% | -48.31% |
Average DrawdownAverage peak-to-trough decline | -30.31% | -7.10% | -23.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.08% | 4.42% | +10.66% |
Volatility
ARKK vs. XLV - Volatility Comparison
ARK Innovation ETF (ARKK) has a higher volatility of 9.21% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 6.35%. This indicates that ARKK's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKK | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.21% | 6.35% | +2.86% |
Volatility (6M)Calculated over the trailing 6-month period | 27.14% | 11.91% | +15.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.37% | 15.86% | +20.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.49% | 14.98% | +31.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.43% | 16.63% | +23.80% |
ARKK vs. XLV - Expense Ratio Comparison
ARKK has a 0.75% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
ARKK vs. XLV - Dividend Comparison
ARKK has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.59%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKK ARK Innovation ETF | 0.00% | 0.00% | 0.00% | 0.70% | 0.00% | 0.55% | 1.64% | 0.38% | 3.14% | 1.32% | 0.00% | 2.27% |
XLV State Street Health Care Select Sector SPDR ETF | 1.59% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
ARKK and XLV have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKK has higher volatility (9.21%) compared to XLV (6.35%). In terms of maximum drawdown, ARKK dropped -80.97% vs XLV's -39.17%.
On 10-year performance, ARKK leads with 14.94% vs 9.64% for XLV. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 6.35%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKK has performed better with a 14.94% return vs 9.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.75% for ARKK.
XLV has the higher dividend yield at 1.59%, compared with 0.00% for ARKK.
ARKK is categorized as Technology Equities, while XLV is Health & Biotech Equities. They also come from different issuers: ARK and State Street. Their fees differ too: 0.75% for ARKK and 0.08% for XLV.
XLV currently has the higher Sharpe Ratio (1.45 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKK and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer